Drug therapy - Treatment of breast cancer

被引：586
作者：
Hortobagyi, GN [1 ]
机构：
[1] Univ Texas, MD Anderson Cancer Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1998年 / 339卷 / 14期
关键词：
D O I：
10.1056/NEJM199810013391407
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：974 / 984
页数：11
相关论文
共 117 条
[1]  
ABE O, 1992, LANCET, V339, P71
[2]  
ABE O, 1995, NEW ENGL J MED, V333, P1444
[3]  
Abe O, 1996, NEW ENGL J MED, V334, P1003
[4]   CHEMOTHERAPY AND SURVIVAL IN ADVANCED BREAST-CANCER - THE INCLUSION OF DOXORUBICIN IN COOPER TYPE REGIMENS [J].
AHERN, RP ;
SMITH, IE ;
EBBS, SR .
BRITISH JOURNAL OF CANCER, 1993, 67 (04) :801-805
[5]  
ANDERSON DE, 1992, CANCER-AM CANCER SOC, V70, P1740, DOI 10.1002/1097-0142(19920915)70:4+<1740::AID-CNCR2820701615>3.0.CO
[6]  
2-1
[7]  
[Anonymous], 1996, Lancet, V348, P1189
[8]   High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America [J].
Antman, KH ;
Rowlings, PA ;
Vaughan, WP ;
Pelz, CJ ;
Fay, JW ;
Fields, KK ;
Freytes, CO ;
Gale, RP ;
Hillner, BE ;
Holland, HK ;
Kennedy, MJ ;
Klein, JP ;
Lazarus, HM ;
McCarthy, PL ;
Saez, R ;
Spitzer, G ;
Stadtmauer, EA ;
Williams, SF ;
Wolff, S ;
Sobocinski, KA ;
Armitage, JO ;
Horowitz, MM .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) :1870-1879
[9]  
Ballo MS, 1996, CANCER, V78, P773
[10]   Phase II study of weekly intravenous recombinant humanized Anti-p185(HER2) monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast [J].
Baselga, J ;
Tripathy, D ;
Mendelsohn, J ;
Baughman, S ;
Benz, CC ;
Dantis, L ;
Sklarin, NT ;
Seidman, AD ;
Hudis, CA ;
Moore, J ;
Rosen, PP ;
Twaddell, T ;
Henderson, IC ;
Norton, L .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :737-744
12345678910